UK Licensed & Regulated Pharmacy
MHRA Compliant Medication
Privacy Assured
Images Are For Illustration Purposes Only

Nevolat (Lirglutide)

From £5.99 In Stock
Only £1 per pack!
Out of Stock!
UK Licensed & Regulated Pharmacy
MHRA Compliant Medication
Privacy Assured
Images Are For Illustration Purposes Only
Other Options Include

Nevolat is a weight loss pen that helps tackle obesity and contains the active ingredient Liraglutide. Liraglutide is a GLP-1 receptor agonist, which means it binds to these receptors and mimics the sensation of feeling full.

How Are Nevolat and Mounjaro Different??

Mounjaro (tirzepatide) and Nevolat (liraglutide) are both injectable treatments used to support weight management, but they work in slightly different ways and may suit different patients. Nevolat is a GLP-1 receptor agonist, while Mounjaro targets both GLP-1 and GIP receptors, which may offer added benefits for some individuals. Mounjaro is taken once weekly but Nevolat is taken daily, both can be highly effective when combined with lifestyle changes. Choosing between them depends on factors such as treatment goals, side effect profile, availability, and individual response, which is why professional guidance is essential.

Feature Mounjaro Nevolat
Generic Name Tirzepatide Lirglutide
Mechanism Dual GLP-1 & GIP receptor agonist GLP-1 receptor agonist
Weight Loss Efficacy Mean weight loss over 72 weeks: 15% (5 mg), 19.5% (10 mg), 21% (15 mg); some variability Mean weight loss over 52 weeks: 8%
Cardiovascular Benefit Not fully established; currently under investigation Not fully established; currently under investigation
Dosing Frequency Once weekly Once daily
Available Strengths 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg 6mg/ml pre-filled multi use pen
Titration Gradual weekly increases to reach target dose Gradual weekly increases to reach target dose
Nausea, vomiting, diarrhea, constipation, indigestion, headache Nausea, vomiting, diarrhea, constipation, indigestion, headache
Price (UK Sept 2025) £133–£330 depending on strength; set to rise ~170%
Common Side Effects 3 pack £102.99, 5 pack £154.99
Contraception Additional barrier method required on top of normal contraceptives Additional barrier method required on top of normal contraceptives
Availability / Supply Widely available, no anticipated supply issues Widely available, no anticipated supply issues

Nevolat is considerably priced lower than the two market leaders Mounjaro across all strenghts and Wegovy. Making it the more cost-effective option for most patients. While some individuals on lower doses of Mounjaro may still find the treatment manageable, those on higher doses often benefit from switching to Nevolat to help reduce costs while maintaining treatment effectiveness.

Nevolat IQ Doctor Price (£) Wegovy Strength IQDoctor Wegovy Price (£) Mounjaro Strength Mounjaro Prices (£) after Sep 1st
6mg/ml 3 pack £102.99 0.25mg 129.99 2.5mg 174.99
6mg/ml 5 pack £154.99 0.5mg 127.99 5mg 194.99
1.0mg 127.99 7.5mg 244.99
1.7mg 199.99 10mg 274.99
2.4mg 241.99 12.5mg 294.99
7.2mg Coming soon 15mg 304.99

Nevolat is a weight loss pen that helps tackle obesity and contains the active ingredient Liraglutide. Liraglutide is a GLP-1 receptor agonist, which means it binds to these receptors and mimics the sensation of feeling full.

Order Journey — Step by Step

Note: Next Day Delivery is counted from the time your prescription is approved by our prescriber, not from when you place your order.

Online Questionnaire

Complete our secure medical questionnaire so our prescribers can confirm treatment is safe and suitable for you.

Order & Payment

Place your order and pay — payment is held securely while the prescriber reviews your case.

If it's not suitable you will receive a full refund.
Upload Images

Upload BMI images, a copy of your ID, and any additional evidence (if requested).

Check your spam/junk folder to avoid delays.
Prescriber Review

A qualified clinician reviews your questionnaire and images. Respond promptly to any follow-up requests to avoid delays.

Approval & Dispatch

Once approved, we aim to dispatch for next-day delivery. Orders approved after the cut-off will be sent the next working day.

We take every step to maintain cold chain conditions (2°C – 8°C) during storage and transport of your Nevolat (Lirglutide) , as this provides a stable environment for the medicine.

Once your Pen Arrives:

  • We recommend placing it in your refrigerator (2°C – 8°C) until you are ready to use it.
  • Protect it from light by keeping it in its original carton.
  • Do not freeze — if frozen, the pen should not be used.

If your pen arrives at room temperature (up to 30°C), you can still use it.

  • Nevolat (Lirglutide) can be kept at temperatures up to 30°C for a maximum of 6 weeks
  • The first pen (6mg/ml) will take 4 weeks to complete then you should order 3mg pen for maintenance
  • Store away from direct sunlight and heat.
  • Always attach the pen cap before storage and never store with a needle attached.

Nevolat Frequently asked questions

Everything you need to know about Nevolat

The brand name for liraglutide is Nevolat, a once-daily injection used to support long-term, sustained weight management. Nevolat works by mimicking a natural gut hormone (GLP-1) that helps regulate appetite, making you feel fuller for longer and reducing overall food intake.
Nevolat (liraglutide) is a prescription medication for adults who are looking to lose weight and improve health outcomes related directly to obesity. It is generally recommended for:
  • Adults with obesity: Body Mass Index (BMI) of 30 or higher (BMI of 27 or higher for people of asian/black or arab origin)
  • Adults who are overweight: BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Nevolat works alongside a reduced-calorie diet and increased physical activity to help achieve and maintain weight loss.
Although Nevolat is licensed for people younger than 18, our clinic only serves patients aged 18 to 75 years. This is because additional precautions are required when prescribing and monitoring medication as part of a distance-selling service.
  • Nevolat is a once-daily injection in the tummy, thigh, or upper arm
  • The dose is started low and increased gradually to reduce side effects.
  • There are 5 doses of Nevolat available: 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3.0 mg. You start on the lowest dose and then work your way up each week if your pharmacist thinks you need to. You have one injection a day.
  • It is used alongside a reduced-calorie diet and increased physical activity for best results
Losing weight with Nevolat isn’t just about appearance. Clinical trials have shown improvements in:
  • Blood pressure
  • Cholesterol and blood sugar levels
  • Mobility and physical function
  • Overall quality of life
Even a 5–10% reduction in weight can reduce the risk of developing diabetes, heart disease, and certain cancers.
Nevolat (liraglutide) acts on the GLP-1 receptor to support appetite suppression and weight management, and it is available at a more affordable price point. Mounjaro (tirzepatide) targets both the GLP-1 and GIP receptors, providing a dual mechanism of action for appetite control, though typically at a higher cost. Both are effective injectable options for weight management. People using Nevolat can expect to lose up to 8% of their starting body weight in just over a year compared to 20% with Mounjaro.
Yes, many people can transition if supply issues or personal choice make Nevolat preferable to Mounjaro. There are no head-to-head “switch” trials, so the decision should be individualised. A healthcare professional will guide you on when to stop one and start the other. It is advisable that all patients take a minimum 7-14 day washout period before switching over from Wegovy/Mounjaro. There are many factors to consider when switching and our team of expert clinicians will review your order and ensure you start at the correct dose.
All three agents Mounjaro, Wegovy and Nevolat are effective for weight management, but individual results vary. Clinical trials have shown average weight reductions of around 15–21% with Mounjaro (depending on dose); about 15% with Wegovy at its full dose and 8% with Nevolat.
The choice often depends on personal factors such as cost, availability, treatment goals, and how well you respond to the medication. If you’re stable and progressing on Mounjaro and cost is not a concern, continuing may be the best option. If affordability or access is an issue, Nevolat can be an option for many people. Clinical trial data provides useful benchmarks, but your individual response matters most. Your healthcare provider will guide your treatment plan, adjust your dosing, and monitor your progress to help you achieve safe and sustainable weight loss. Nevolat may be preferable if you want a once-daily regimen or if you find the side effects of Mounjaro to be less tolerable.
  • Starting at the lowest effective dose: Starting low is the best way to reduce GI side effects, but this has to be balanced with keeping your appetite at bay
  • Gradual dose titration, as guided by your healthcare provider, can reduce GI symptoms
  • Stay consistent: Side effects often lessen over time as your body adjusts
  • Speak to your clinician: Your clinician can provide strategies to manage discomfort and monitor your response to the new medication